Arterial blood pressure decrease following adrenergic  -receptor stimulation in the central nervous system.
D000317:Adrenergic alpha-Antagonists / Q000494:pharmacology*; D000814:Aniline Compounds / Q000494:pharmacology; D000818:Animals; D001158:Arteries; D001794:Blood Pressure / Q000187:drug effects*; D001933:Brain Stem / Q000187:drug effects; D002415:Cats; D002552:Cerebral Ventricles / Q000187:drug effects*; D002800:Cholinesterase Inhibitors; D004298:Dopamine / Q000494:pharmacology; D007022:Hypotension / Q000139:chemically induced; D008750:Methyldopa / Q000494:pharmacology; D009474:Neurons / Q000187:drug effects; D009638:Norepinephrine / Q000494:pharmacology; D013843:Thiazines / Q000494:pharmacology; D014992:Xylenes / Q000494:pharmacology
D000317:Adrenergic alpha-Antagonists; D000814:Aniline Compounds; D002800:Cholinesterase Inhibitors; D013843:Thiazines; D014992:Xylenes; D008750:Methyldopa; D004298:Dopamine; D009638:Norepinephrine